electroCore (ECOR) Non-Current Deffered Revenue (2017 - 2018)
electroCore's quarterly Non-Current Deffered Revenue came in at $245632.0 in Q4 2018, down 19.96% year-on-year from $306886.0 in Q4 2017, and down 6.42% quarter-over-quarter from $262497.0 in Q3 2018.
electroCore has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $245632.0 in Q4 2018.
- For the quarter ending Q4 2018, Non-Current Deffered Revenue fell 19.96% year-over-year to $245632.0; the trailing twelve-month figure through Dec 2018 stood at $245632.0 (down 19.96% YoY), and the FY2018 full-year result was $245632.0, down 19.96% from the prior year.
- Non-Current Deffered Revenue for Q4 2018 stood at $245632.0, down from $262497.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $306886.0 in Q4 2017, with the low at $245632.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 245,632.00 |
| Sep 30, 2018 | 262,497.00 |
| Jun 30, 2018 | 279,362.00 |
| Dec 31, 2017 | 306,886.00 |